What is Competact?
Competact is a medicine available as tablets containing two active substances, pioglitazone (15 mg) and metformin hydrochloride (850 mg).
What is Competact used for?
Competact is used in adults with type 2 diabetes. Competact is used in patients that are not satisfactorily controlled on metformin (a diabetes medicine) used on its own and at the maximum possible dose.
How is Competact used?
The usual dose of Competact is one tablet taken twice a day. Patients changing from metformin only to Competact may need to slowly introduce pioglitazone until a dose of 30 mg per day is reached.
How does Competact work?
Type-2 diabetes is a disease in which the pancreas does not make enough insulin to control the level of glucose in the blood or when the body is unable to use insulin effectively.
Other information about Competact
The European Commission granted a marketing authorisation valid throughout the European Union, for Competact on 28 July 2006.